Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Engage
Data as at: 11/06/2026
In
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
AIC sector
Management group
Company website
Launch date
28/04/1995
March
Domicile
United Kingdom
Fund manager
Sven H. Borho, Trevor M. Polischuk
Dividend frequency
Semi-Annually
Wind-up provisions
Shareholders have approve the continuance of the Company as an investment trust for a further period of five years. Continuation vote at every fifth AGM, the next of which will be in 2029.
Continuation vote
5 yearly
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 1,263.10 | 1,372.42 | 348.50 | 377.18 | -7.60 | 0 | 0.69 | Jun, Nov | 0.9 (31/03/2026) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 11/06/2026 | 23/07/2026 | 1.700 | No | 2026 |
| 27/11/2025 | 09/01/2026 | 0.700 | No | 2026 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Worldwide Healthcare Trust | Share price total return | 15.3 | 10.0 | -2.7 | 109.9 |
| Healthcare & Biotechnology AIC sector | Share price total return | 27.8 | 8.0 | -9.9 | 93.7 |
Scroll
Share structure
Number of shares
362,438,777
239,226,423
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 641,305 | 20,387,875 | 373,466,209 | 1,554,385,394 |
| Average | N/A | 926,722 | 1,476,150 | 1,232,660 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 2.23 | 70.73 | 1,264.45 | 5,114.64 |
| Average | N/A | 3.22 | 5.00 | 4.06 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00BN455J50 | WWH | GBX | London Stock Exchange - MAIN Boerse Berlin Chi-x Europe Limited London Stock Exchange Pink Sheets Llc (nqb) |
Scroll
Top holdings
Data as at : 28/02/2026
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 11.3 |
| Boston Scientific Corp | 7.5 |
| AstraZeneca PLC | 6.1 |
| Roche Holding AG | 4.7 |
| Intuitive Surgical Inc | 4.5 |
| Edwards Lifesciences Corp | 4.4 |
| Merck & Co Inc | 4.2 |
| argenx SE ADR | 3.5 |
| Stryker Corp | 3.1 |
| Alnylam Pharmaceuticals Inc | 3.0 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
